Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MicroRNA-223 is a key factor in osteoclast differentiation.

T Sugatani1, K A Hruska

  • 1Department of Pediatrics, Pathobiology Unit, Washington University School of Medicine, St Louis, MO 63110, USA. sugatani_t@kids.wustl.edu

Journal of Cellular Biochemistry
|May 2, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiological condition differentially affects the behavior and survival of two populations of sockeye salmon during their freshwater spawning migration.

Physiological and biochemical zoology : PBZ·2010
Same author

Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.

European journal of clinical investigation·2006
Same author

New insights into mineral and skeletal regulation by active forms of vitamin D.

Kidney international·2006
Same author

Osteopontin.

Drug news & perspectives·2004
Same author

Differential growth factor control of bone formation through osteoprogenitor differentiation.

Bone·2004
Same author

Impairment of the collagenase-3 endocytotic receptor system in cells from patients with osteoarthritis.

Osteoarthritis and cartilage·2003
Same journal

Zinc Finger Proteins as Regulators of Organ Fibrosis.

Journal of cellular biochemistry·2026
Same journal

Intrinsic Disorder Status in Human Proteins Interacting With SARS-CoV-2 Proteins: Insights From Five Years of Translational Research.

Journal of cellular biochemistry·2026
Same journal

The Effect of Protein Tagging on Aggregation and Phase Separation.

Journal of cellular biochemistry·2026
Same journal

TRIM32 Alleviates the Inflammation in Spinal Cord Injury Progression Through Inducing the Ubiquitination Degradation of TLR4.

Journal of cellular biochemistry·2026
Same journal

Bedaquiline Binding at the Leading Site of Mycobacterium tuberculosis ATP Synthase Induces Distinct Structural and Dynamic Changes.

Journal of cellular biochemistry·2026
Same journal

Agrin Ablation in Osteoblasts Compromises Long Bone Structure and Osteoblastic Differentiation of Mesenchymal Stem Cells.

Journal of cellular biochemistry·2026
See all related articles

MicroRNA-223 (miR-223) is crucial for regulating osteoclast differentiation, a key process in bone metabolism. Overexpression of miR-223 inhibits this differentiation, suggesting its therapeutic potential for bone disorders.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) regulate gene expression in animals and plants.
  • The role of miRNAs in bone metabolism, particularly osteoclast differentiation, remains largely unexplored.
  • Osteoclast activity is critical for bone remodeling and implicated in metabolic bone diseases.

Purpose of the Study:

  • To investigate the role of microRNA-223 (miR-223) in osteoclast differentiation.
  • To determine the effect of miR-223 modulation on osteoclast formation in vitro.
  • To assess the potential of miR-223 as a therapeutic target for bone metabolic disorders.

Main Methods:

  • Utilized RAW264.7 cells, a mouse osteoclast precursor cell line.
  • Constructed retroviral vectors for miR-223 knockdown (siRNA) and overexpression (pre-miR-223).

Related Experiment Videos

  • Assessed osteoclast differentiation by quantifying tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells.

    • Main Results:

    • miR-223 was expressed in RAW264.7 cells.
    • miR-223 knockdown did not significantly affect TRAP-positive multinucleated cell formation compared to controls.
    • Overexpression of pre-miR-223 completely inhibited TRAP-positive multinucleated cell formation, indicating a critical role in blocking differentiation.
    • No significant apoptosis was observed in any experimental group.

    Conclusions:

    • miR-223 plays an essential role in regulating osteoclast differentiation.
    • Modulating miR-223 levels can inhibit osteoclast formation.
    • miR-223 represents a potential therapeutic target for bone metabolic disorders characterized by excessive osteoclast activity.